Arvinas, Inc. (ARVN) earnings

ARVN earnings moved a median of -0.48% by the close. Quarterly and annual ARVN reports and results, each read against the price at its own news timestamp. Back to the ARVN overview →

27 measured ARVN earnings events.

Where these ARVN earnings landedvs 27 measured ARVN earnings reactions
ARVN earningsMiddle 50% · -3.45% to +2.47%Zero: 0.00%Median: -0.48%Median -0.48%-5.00%0+5.00%
Middle 50% of ARVN earnings reactions-3.45% to +2.47%
Median reaction (to close)-0.48%
Measured reactions27
Point-in-time · zero look-ahead

Half of the 27 ARVN earnings events with a measured close landed between -3.45% and +2.47%; 44% closed up.

DateHeadlineEvent5-minTo close
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate UpdatePress release+8.58%+6.51%
Form 10-Q ARVINAS, INC. For: Jun 30SEC filing · Form 10-Q+0.23%-4.76%
Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026Press release-0.61%-0.48%
Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate UpdatePress release-5.33%-2.65%
Form 10-Q ARVINAS, INC. For: Mar 31SEC filing · Form 10-Q-5.33%-2.65%
Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026Press release+0.37%-1.76%
Form 10-K ARVINAS, INC. For: Dec 31SEC filing · Form 10-K+1.00%+2.43%
Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate UpdatePress release+1.43%+1.49%
Form 10-Q ARVINAS, INC. For: Sep 30SEC filing · Form 10-Q+0.93%+2.99%
Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025Press release+0.85%+1.91%
Arvinas Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatePress release-4.21%-9.69%
Form 10-Q ARVINAS, INC. For: Jun 30SEC filing · Form 10-Q-0.30%-6.02%
Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025Press release+0.80%-0.93%
Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate UpdatePress release+0.94%+13.68%
Form 10-Q ARVINAS, INC. For: Mar 31SEC filing · Form 10-Q-2.83%+3.90%
Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025Press release+0.44%+1.54%
Form 10-K ARVINAS, INC. For: Dec 31SEC filing · Form 10-K+0.80%+2.51%
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatePress release+2.20%-0.14%
Form 10-Q ARVINAS, INC. For: Sep 30SEC filing · Form 10-Q-1.48%-2.15%
Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024Press release+0.30%-4.66%
Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatePress release+0.38%-6.23%
Form 10-Q ARVINAS, INC. For: Jun 30SEC filing · Form 10-Q-1.03%+0.77%
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate UpdatePress release+0.15%+5.99%
Form 10-Q ARVINAS, INC. For: Mar 31SEC filing · Form 10-Q-0.34%-3.52%
Form 10-K ARVINAS, INC. For: Dec 31SEC filing · Form 10-K+0.41%-3.39%
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatePress release-1.32%+4.04%
Form 10-Q ARVINAS, INC. For: Sep 30SEC filing · Form 10-Q-3.26%-7.14%
That’s how ARVN usually reacts to earnings — get an email when it moves on news →
Keep exploring

More ARVN: analyst actions → · SEC filings → · ARVN overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
ROCHE HOLDING LTD S/ADR (RHHBY)449+0.03%52%
CareDx, Inc. (CDNA)443-0.11%47%
Jaguar Health, Inc. (JAGX)442-0.38%41%
BOVIE MEDICAL (BVX)4410.00%46%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.